Sparsentan
TVTX-RE021-426
Approved small_molecule active
Quick answer
Sparsentan for Proteinuria is a Approved program (small_molecule) at Travere Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Travere Therapeutics
- Indication
- Proteinuria
- Phase
- Approved
- Modality
- small_molecule
- Status
- active